CHRONIC ILLNESS PATIENT ON BENZODIAZEPINES AND OPIOIDS

In July 2020, remimazolam besylate (manufacturer: Byfavo) was authorized with the FDA for that induction and routine maintenance of procedural sedation in Older people undergoing processes Long lasting 30 minutes or less.From the US, benzodiazepines are classified being a Schedule IV drug. This implies a large danger for abuse but apparent health-r